Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham W Donald

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|February 22, 2013
CXCR2: a target for pancreatic cancer treatment?Kathleen M Hertzer, Graham W Donald, O Joe Hines
Surgery|August 30, 2016
Perineural bupivacaine injection reduces inguinodynia after inguinal hernia repairJoseph G Crompton, Aaron J Dawes, Graham W Donald, et al.
The American Surgeon|September 30, 2014
Trauma system overtriage: are we on track?Zoe Fullerton, Graham W Donald, Henry G Cryer, et al.
Journal of Vascular Surgery|May 19, 2018
Preoperative frailty assessment predicts loss of independence after vascular surgeryGraham W Donald, Amir A Ghaffarian, Farid Isaac, et al.
Surgery|May 14, 2013
Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage?Graham W Donald, Dharma Sunjaya, Xuyang Lu, et al.
Biochemical and Biophysical Research Communications|August 27, 2013
miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cellsHung Pham, C Ekaterina Rodriguez, Graham W Donald, et al.
Annals of Surgical Oncology|August 15, 2013
Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging systemMatthew M Rochefort, Jacob S Ankeny, Brian E Kadera, et al.
JAMA Surgery|December 6, 2013
Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survivalBrian E Kadera, Dharma B Sunjaya, William H Isacoff, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|February 22, 2013
CXCR2: a target for pancreatic cancer treatment?Kathleen M Hertzer, Graham W Donald, O Joe Hines
Surgery|August 30, 2016
Perineural bupivacaine injection reduces inguinodynia after inguinal hernia repairJoseph G Crompton, Aaron J Dawes, Graham W Donald, et al.
The American Surgeon|September 30, 2014
Trauma system overtriage: are we on track?Zoe Fullerton, Graham W Donald, Henry G Cryer, et al.
Journal of Vascular Surgery|May 19, 2018
Preoperative frailty assessment predicts loss of independence after vascular surgeryGraham W Donald, Amir A Ghaffarian, Farid Isaac, et al.
Surgery|May 14, 2013
Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage?Graham W Donald, Dharma Sunjaya, Xuyang Lu, et al.
Biochemical and Biophysical Research Communications|August 27, 2013
miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cellsHung Pham, C Ekaterina Rodriguez, Graham W Donald, et al.
Annals of Surgical Oncology|August 15, 2013
Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging systemMatthew M Rochefort, Jacob S Ankeny, Brian E Kadera, et al.
JAMA Surgery|December 6, 2013
Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survivalBrian E Kadera, Dharma B Sunjaya, William H Isacoff, et al.
Pageof 1